Literature DB >> 422967

HLA antigens in chronic relapsing idiopathic inflammatory polyneuropathy.

D Adams, H Festenstein, J D Gibson, R A Hughes, J Jaraquemada, C Papasteriadis, J Sachs, P K Thomas.   

Abstract

Observations are reported on 14 patients with a clinical diagnosis of recurrent or chronic relapsing idiopathic inflammatory polyneuropathy of Guillain-Barré type. The results suggest the possibility of a disease susceptibility gene for this disorder associated with the HLA-A1, -B8, -DRw3, and -Dw3 haplotype.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 422967      PMCID： PMC490186          DOI： 10.1136/jnnp.42.2.184

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  5 in total

1.  Chronic inflammatory polyradiculoneuropathy.

Authors:  P J Dyck; A C Lais; M Ohta; J A Bastron; H Okazaki; R V Groover
Journal:  Mayo Clin Proc       Date:  1975-11       Impact factor: 7.616

2.  Recurrent experimental allergic neuritis. An electron microscope study.

Authors:  J D Pollard; R H King; P K Thomas
Journal:  J Neurol Sci       Date:  1975-03       Impact factor: 3.181

3.  Recurrent and chronic relapsing Guillain-Barré polyneuritis.

Authors:  P K Thomas; R G Lascelles; J F Hallpike; R L Hewer
Journal:  Brain       Date:  1969       Impact factor: 13.501

4.  HLA antigens in Guillain-Barré syndrome.

Authors:  D Adams; J D Gibson; P K Thomas; J R Batchelor; R A Hughes; L Kennedy; H Festenstein; J Sachs
Journal:  Lancet       Date:  1977-09-03       Impact factor: 79.321

5.  HLA antigens in the Landry-Guillain-Barré syndrome and chronic relapsing polyneuritis.

Authors:  G J Stewart; J D Pollard; J G McLeod; C M Wolnizer
Journal:  Ann Neurol       Date:  1978-09       Impact factor: 10.422
  5 in total
  6 in total

Review 1.  Management of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard A C Hughes
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Chronic relapsing inflammatory polyneuropathy complicating sicca syndrome.

Authors:  M Gross
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-07       Impact factor: 10.154

3.  HLA antigens in chronic inflammatory demyelinating polyneuropathy.

Authors:  D J Feeney; J D Pollard; J G McLeod; G J Stewart; T J Doran
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

4.  Chronic inflammatory demyelinating polyneuropathy in two siblings.

Authors:  A A Gabreëls-Festen; A T Hageman; F J Gabreëls; E M Joosten; W O Renier; C M Weemaes; H J ter Laak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

5.  The epidemiology of inflammatory polyradiculoneuropathy. A critical review of the distribution, characteristics and outcome of the disease. Plasmapheresis Study Group.

Authors:  E Beghi; F Cornelio; M Marconi; N Rizzuto; P Tonali
Journal:  Ital J Neurol Sci       Date:  1991-02

6.  The treatment of inflammatory polyneuropathy by plasma exchange.

Authors:  M L Gross; N J Legg; M C Lockwood; C Pallis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-08       Impact factor: 10.154
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.